Christopher N. Floyd
Impact in
- Internal Medicine top 5%
- Venous Thromboembolism Diagnosis and Management
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
- Blood Pressure and Hypertension Studies
- Acute Myocardial Infarction Research
Papers in
-
- Blood Pressure and Hypertension Studies 11
- Antiplatelet Therapy and Cardiovascular Diseases 9
- Atrial Fibrillation Management and Outcomes 4
- Heart Rate Variability and Autonomic Control 4
- Co-authors
- Albert FerroAnthony S. WierzbickiGabriella PassacqualeMargaret ConstantiMark GloverRichard J. McManusPhil ChowienczykDavid M. Wood
- Journals
- British Journal of Clinical Pharmacology (7 papers)Hypertension (3 papers)Journal of Hypertension (2 papers)BMJ (2 papers)PLoS ONE (2 papers)
- Partner nations
- United KingdomAustraliaCanada
In The Last Decade
Christopher N. Floyd
30 papers receiving 487 citations
Peers
Comparison fields: 5 of 103
- Internal Medicine 91
- Cardiology and Cardiovascular Medicine 329
- Hematology 80
- Pharmacology 80
- Endocrinology, Diabetes and Metabolism 51
Countries citing papers authored by Christopher N. Floyd
This map shows the geographic impact of Christopher N. Floyd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher N. Floyd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher N. Floyd more than expected).
Fields of papers citing papers by Christopher N. Floyd
This network shows the impact of papers produced by Christopher N. Floyd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher N. Floyd. The network helps show where Christopher N. Floyd may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christopher N. Floyd, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2021 | 13 | |
| 3 | 2021 | 1 | |
| 4 | 2020 | 4 | |
| 5 | 2020 | 13 | |
| 6 | 2020 | 4 | |
| 7 | 2020 | 2 | |
| 8 | 2020 | 12 | |
| 9 | 2019 | 55 | |
| 10 | 2019 | 9 | |
| 11 | 2017 | 10 | |
| 12 | 2017 | 25 | |
| 13 | 2016 | 3 | |
| 14 | 2015 | 31 | |
| 15 | 2015 | 7 | |
| 16 | 2014 | 26 | |
| 17 | 2014 | 1 | |
| 18 | 2014 | 27 | |
| 19 | 2013 | 123 | |
| 20 | 2012 | 58 |
About Christopher N. Floyd
Christopher N. Floyd is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Family Practice, Endocrinology, Diabetes and Metabolism and Hematology, having authored 30 papers that have together received 505 indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (11 papers), Antiplatelet Therapy and Cardiovascular Diseases (9 papers), Atrial Fibrillation Management and Outcomes (4 papers), Diabetes Treatment and Management (4 papers), Heart Rate Variability and Autonomic Control (4 papers), Platelet Disorders and Treatments (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Sodium Intake and Health (2 papers). The work is most often cited by research in Internal Medicine (91 citations), Cardiology and Cardiovascular Medicine (329 citations), Hematology (80 citations), Pharmacology (80 citations) and Endocrinology, Diabetes and Metabolism (51 citations). Christopher N. Floyd has collaborated with scholars based in United Kingdom, Australia and Canada. Frequent co-authors include Albert Ferro, Anthony S. Wierzbicki, Gabriella Passacquale, Margaret Constanti, Mark Glover, Richard J. McManus, Phil Chowienczyk, David M. Wood, K. McNeill and David J. Webb. Their work appears in journals such as British Journal of Clinical Pharmacology, Hypertension, Journal of Hypertension, BMJ and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.